Sightsavers, 35 Perrymount Road, Haywards Heath, England, UK RH16 3BZ.
Coalition for Operational Research on Neglected Tropical Diseases, Task Force for Global Health, 330 West Ponce de Leon Avenue, Decatur, GA, 30030, USA.
Int Health. 2022 Apr 6;14(Suppl 1):i17-i23. doi: 10.1093/inthealth/ihab083.
Onchocerciasis is targeted for elimination of transmission by 2030 in at least 21 countries. To achieve this, recent and accurate data on the extent and intensity of onchocerciasis transmission are required. This will include mapping areas previously unassessed, or remapping of areas that were last visited as part surveys aiming to prevent blindness, not assess transmission in totality. There is near universal acceptance of the need to carry out these mapping reassessments, to achieve equitable and lasting elimination of onchocerciasis transmission. However, there is no consensus on how to conduct onchocerciasis elimination mapping (OEM), and little published data to inform policymakers and programme managers, including on cost.
Here, we summarise the methods and cost implications of conducting pilot OEM surveys in Ghana and Nigeria in 2018. We have included a breakdown of costs incurred overall, per person and per implementation unit in each country, as well as detailed analysis of the cost categories and the main cost drivers.
The procurement and logistics of diagnostics accounted for more than one-third of the total cost, a significant cost driver.
This information will be valuable to policymakers and donors as they seek to prioritise onchocerciasis elimination and plan to complete OEM.
到 2030 年，至少有 21 个国家的目标是消除盘尾丝虫病的传播。为了实现这一目标，需要掌握最近和准确的关于盘尾丝虫病传播范围和强度的数据。这将包括对以前未评估的地区进行绘图，或对最后一次作为旨在预防失明的调查的一部分访问的地区进行重新绘图，而不是对总体传播情况进行评估。普遍接受需要进行这些绘图重新评估，以实现公平和持久消除盘尾丝虫病传播。然而，对于如何进行盘尾丝虫病消除绘图（OEM），尚未达成共识，而且很少有关于成本的出版物数据可供政策制定者和方案管理人员参考。
在这里，我们总结了 2018 年在加纳和尼日利亚进行试点 OEM 调查的方法和成本影响。我们包括了两国总体、每人和每个实施单位的成本细目，以及对成本类别和主要成本驱动因素的详细分析。
诊断试剂的采购和物流占总成本的三分之一以上，是一个重要的成本驱动因素。
随着决策者和捐助者寻求优先考虑消除盘尾丝虫病并计划完成 OEM，这些信息将具有重要价值。
